![Murali Srivathsa](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Murali Srivathsa
Chief Executive Officer at Akura Medical, Inc.
Profile
Murali Srivathsa is currently the President & Chief Executive Officer at Akura Medical, Inc. He is also a Director at Zoll Medical Israel Ltd.
Previously, he worked as the Vice President-Sales & Marketing at Medtronic Monitoring, Inc. Mr. Srivathsa holds an MBA from the International Institute for Management Development.
He also completed his undergraduate studies at the University of Bangalore and his graduate studies at The Indian Institute of Foreign Trade.
Murali Srivathsa active positions
Companies | Position | Start |
---|---|---|
Zoll Medical Israel Ltd.
![]() Zoll Medical Israel Ltd. Information Technology ServicesTechnology Services Zoll Medical Israel Ltd. develops patient monitoring solutions for chronic cardiac illnesses. It has developed a proprietary technology for the detection and monitoring of changes in fluid contents, based on a proprietary RF sensing technology. The firm’s solutions are designed to provide healthcare professionals with accurate and reliable information on the patient's clinical status for support of medical decision-making. The company was founded by y Murali Srivathsa, Uriel Weinstein, Assaf Bernstein, Michal Shohat in 2008 and is headquartered in Kfar Saba, Israel. | Director/Board Member | - |
Akura Medical, Inc.
![]() Akura Medical, Inc. Medical SpecialtiesHealth Technology Akura Medical, Inc. is a privately held medical device company that is developing a next-generation thrombectomy device to simplify thrombectomy through an easy-to-use, single-pass procedure that efficiently removes blood clots. Akura Medical is based in Campbell, CA. The company is focused on delivering an effective solution to address the major challenges of venous thromboembolism (VTE). The company was founded in 2019 by Amr Salahieh, Aadel Al-Jadda. Murali Srivathsa has been the CEO of the company since 2022. | Chief Executive Officer | 2022-04-18 |
Former positions of Murali Srivathsa
Companies | Position | End |
---|---|---|
Medtronic Monitoring, Inc.
![]() Medtronic Monitoring, Inc. Medical/Nursing ServicesHealth Services Medtronic Monitoring, Inc. treats cardiac arrhythmias. The company was founded in 2005 and is headquartered in San Jose, CA. | Corporate Officer/Principal | - |
Training of Murali Srivathsa
International Institute for Management Development | Masters Business Admin |
The Indian Institute of Foreign Trade | Graduate Degree |
University of Bangalore | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Medtronic Monitoring, Inc.
![]() Medtronic Monitoring, Inc. Medical/Nursing ServicesHealth Services Medtronic Monitoring, Inc. treats cardiac arrhythmias. The company was founded in 2005 and is headquartered in San Jose, CA. | Health Services |
Zoll Medical Israel Ltd.
![]() Zoll Medical Israel Ltd. Information Technology ServicesTechnology Services Zoll Medical Israel Ltd. develops patient monitoring solutions for chronic cardiac illnesses. It has developed a proprietary technology for the detection and monitoring of changes in fluid contents, based on a proprietary RF sensing technology. The firm’s solutions are designed to provide healthcare professionals with accurate and reliable information on the patient's clinical status for support of medical decision-making. The company was founded by y Murali Srivathsa, Uriel Weinstein, Assaf Bernstein, Michal Shohat in 2008 and is headquartered in Kfar Saba, Israel. | Technology Services |
Akura Medical, Inc.
![]() Akura Medical, Inc. Medical SpecialtiesHealth Technology Akura Medical, Inc. is a privately held medical device company that is developing a next-generation thrombectomy device to simplify thrombectomy through an easy-to-use, single-pass procedure that efficiently removes blood clots. Akura Medical is based in Campbell, CA. The company is focused on delivering an effective solution to address the major challenges of venous thromboembolism (VTE). The company was founded in 2019 by Amr Salahieh, Aadel Al-Jadda. Murali Srivathsa has been the CEO of the company since 2022. | Health Technology |
- Stock Market
- Insiders
- Murali Srivathsa